Advertisement
News
Advertisement

Repligen sees positive results from bioprocessing biz

Thu, 11/08/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Since announcing a renewed focus on its bioprocessing business in August, Repligen Corp. (Nasdaq:RGEN) tripled its net income for the third quarter compared to the previous year, the company said today.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading